Company records / one-carbon.com
One-carbon Therapeutics
One-carbon Therapeutics (one-carbon.com): 2 changes recorded in its website history since October 2021. Homepage last checked 6 November 2026.
Recorded changes
- HeadlineBetween and
One-Carbon Therapeutics
Pioneering novel therapy that exploit cancer’s oncogene addiction
- FundingBetween and
Announced on its homepage: “Learn more Latest news One-carbon Therapeutics announces oversubscribed private placement financing of SEK 153 million (€13.9 million) So…”.
First recorded website
Observed 8 February 2023
One-carbon therapeutics AB is tackling the most difficult to treat cancers, inflammation and autoimmune diseases by targeting the disease specific one-carbon metabolism pathway, representing a novel w
How it describes itself
Pioneering novel therapy that exploit cancer’s oncogene addiction
Summary of the record · AI-written
One-carbon Therapeutics updates homepage and announces financing
One-carbon Therapeutics highlights a new homepage headline and has announced an oversubscribed private placement financing. The company now describes itself as pioneering a novel cancer therapy approach.
- Between July 2025 and January 2026, One-carbon Therapeutics announced on its homepage an oversubscribed private placement financing of SEK 153 million (€13.9 million). [1]
- Between January 2026 and November 2026, One-carbon Therapeutics changed its homepage headline to say it is “pioneering novel therapy that exploit cancer’s oncogene addiction”. [2]
- Reading: The combination of an oversubscribed private placement financing and a new oncology-focused homepage headline between July 2025 and November 2026 may suggest increasing emphasis on developing novel cancer therapies. [1][2]
Cite this record
StartupHistory, “One-carbon Therapeutics” company record, https://startuphistory.org/c/one-carbon.com